Model shows vaccine tied to prevention of 110,000 deaths and a resulting $30.4 billion direct health care cost savings
Increasing Impact of HPV Vaccination Seen in the United States
Impact on 4vHPV-type prevalence in 2015 to 2018 for 14- to 24-year-old females 90 percent among vaccinated, 74 percent among unvaccinated
FDA Authorizes Pfizer Booster Shot for Children Ages 5 to 11 Years
Third shot can be given at least five months after healthy children complete the two-dose vaccine series
Vaccine Effectiveness Modest for Children, Teens During Omicron
BNT162b2 vaccine effectiveness against symptomatic infection modest and declined rapidly, was higher after booster dose in teens
50-µg mRNA-1273 Safe, Effective for Children Aged 6 to 11 Years
Estimated vaccine efficacy with two doses was 88.0 percent against COVID-19 at a time when delta was dominant circulating variant
Company Hid Problems With COVID-19 Vaccines From FDA
Nearly 400 million doses of vaccine made by Emergent had to be destroyed ‘due to poor quality control’
FDA Limits Use of J&J COVID-19 Vaccine Due to Blood Clot Risk
With safer two-dose vaccines such as Pfizer and Moderna widely available, the one-dose J&J shot should be limited
Plant-Based Recombinant COVID-19 Vaccine Found to Be Effective
Vaccine efficacy ranged from 69.5 percent against symptomatic infection to 78.8 percent against moderate-to-severe disease
Only One in Five Parents Plan to Get COVID-19 Vaccine for Children Under 5 When Available
27 percent said they would ‘definitely not’ get their child vaccinated, 11 percent said they would do so only if required
Children’s Mental Health Impacted by Adult COVID-19 Vaccination Rates
Stress surrounding the pandemic declined in U.S. children after vaccinations were rolled out for adults